CVE-2025-1138

IBM Information Server information disclosure

Description

IBM InfoSphere Information Server 11.7 could disclose sensitive information to an authenticated user that could aid in further attacks against the system through a directory listing.

Remediation

Solution:

  • Product VRMF APAR Remediation InfoSphere Information Server, InfoSphere Information Server on Cloud 11.7 DT434891 --Apply InfoSphere Information Server version 11.7.1.0 --Apply InfoSphere Information Server version 11.7.1.6 --Apply Information Server Framework security patch

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.03%
Vendor Advisory ibm.com
Affected: IBM InfoSphere Information Server
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/7230295 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2025-1138?
CVE-2025-1138 has been scored as a medium severity vulnerability.
How to fix CVE-2025-1138?
To fix CVE-2025-1138: Product VRMF APAR Remediation InfoSphere Information Server, InfoSphere Information Server on Cloud 11.7 DT434891 --Apply InfoSphere Information Server version 11.7.1.0 --Apply InfoSphere Information Server version 11.7.1.6 --Apply Information Server Framework security patch
Is CVE-2025-1138 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-1138 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-1138?
CVE-2025-1138 affects IBM InfoSphere Information Server.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.